Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Perugia
Clinical trial register · Italy

Clinical Trials in Perugia, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca10 Hoffmann-La Roche7 ETOP IBCSG Partners Foundation7 Janssen Research & Development, LLC6 Bristol-Myers Squibb6
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in Perugia

141 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
University of Rome Tor Vergata
Not applicable
151
Perugia
2026-11
Recruiting
Evaluation of Diagnostic Accuracy and Clinical Performance of the UllCORE Bloodstream Infection (BSI) Test
NCT07859852Blood Stream Infection, Blood Stream Infections, Sepsis, Fungemia
Deepull Diagnostics S.L.
Observational
1,500
Florence, Perugia
2026-09-21
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Ancona, Bergamo, Brescia, Milan, Pavia, Perugia, Riccione, Salerno
2026-08-24
Recruiting
Bristol-Myers Squibb
Phase 2
260
Siena, Bergamo, Milan, Naples, Perugia
2026-07-27
Recruiting
Novo Nordisk A/S
Phase 3
2,500
Bologna, Genoa, Brescia, Milan, Perugia, Messina, Ancorna, Pisa
2026-05-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
876
Bergamo, Milan, Florence, Perugia, Novara, Roma
2026-05-04
Recruiting
ETOP IBCSG Partners Foundation
Phase 2
48
Meldola, Milan, Perugia, Roma
2026-04-15
Recruiting
Merck Sharp & Dohme LLC
Phase 3
758
Meldola, Rozzano, Catselfranco Veneto, Florence, Bari, Bologna, Milan, Perugia
2026-04-09
Not yet open
Antonio Pierini
Phase 2
28
Perugia, Pescara
2026-04
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Bergamo, Catanzaro, Bologna, Rome, Milan, Palermo, Perugia
2026-03-23
Recruiting
SymBio Pharmaceuticals
Phase 3
180
Genova, Pavia, Perugia, Rome, San Raffaele
2026-03-17
Recruiting
Eli Lilly and Company
Phase 4
150
Alessandria, Florence, Messina, Monza, Perugia, Rome, Terni
2026-03-09
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Ancona, Catania, Milan, Perugia, Roma, Rozzano, Torino, Udine
2026-03-05
Recruiting
IDEAYA Biosciences
Phase 3
520
Naples, Milan, Perugia, Florence, Pisa, Rome
2026-01-25
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
390
Meldola, Milan, Novara, Pavia, Perugia, Prato, Siena, Treviso
2026-01-12
Recruiting
Bristol-Myers Squibb
Phase 2/3
590
Naples, Ravenna, Aviano, Orbassano, Siena, Perugia, Bologna, Milan
2026-01-02
Recruiting
Janssen Research & Development, LLC
Observational
200
Bari, Brescia, Iesi, Milan, Naples, Palermo, Pavia, Perugia
2025-12-04
Recruiting
Optimal Time for Reperfusion in Acute Pulmonary Embolism
NCT07436702Pulmonary Embolism (Diagnosis), Pulmonary Embolism Acute
Azienda ULSS 8 Berica
Observational
500
Milan, Monselice, Pavia, Perugia, Pisa, Torino, Arzignano
2025-11-25
Active, closed
Hoffmann-La Roche
Phase 3
1,060
Naples, Modena, Rome, Perugia
2025-11-12
Recruiting
AstraZeneca
Phase 2
435
Milan, Palermo, Pavia, Perugia, Roma, Rozzano, Torrette
2025-11-06
Recruiting
Personalized Music Therapy for Preterm Infants
NCT07295106Infant, Premature, Stress, Psychological
Fabrizio Faina
Not applicable
20
Perugia
2025-10-13
Recruiting
The Multicentre Selective Lymphadenectomy Trial - 3
NCT07049276Cutaneous Melanoma, Stage III
Melanoma Institute Australia
Not applicable
1,500
Perugia
2025-10-01
Recruiting
Kura Oncology, Inc.
Phase 3
1,300
Bologna, Ravenna, Trieste, Brescia, Ascoli Piceno, Perugia
2025-09-26
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT07011719Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma
DrugsCasdatifan·Cabozantinib
Arcus Biosciences, Inc.
Phase 3
720
Florence, Genova, Milan, Naples, Padua, Perugia, Rome, Rozzano
2025-09-08
Active, closed
Novo Nordisk A/S
Observational
245
Milan, Turin, Livorno, Lucca, Bergamo, Catanzaro, Naples, Perugia
2025-08-28
Recruiting
Novartis Pharmaceuticals
Phase 2
407
Cefalù, Perugia
2025-08-07
Recruiting
Intergruppo Melanoma Italiano
Observational
270
Bari, Genova, Milan, Modena, Naples, Padova, Perugia, Roma
2025-08-04
Recruiting
AbbVie
Phase 2/3
854
Rome, Orbassano, Perugia, Roma
2025-08-03
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Naples, Rome, Genoa, Brescia, Milan, Palermo, Perugia
2025-07-02
Active, closed
Immunovant Sciences GmbH
Phase 2
180
Catania, Milan, Palermo, Perugia, Rome
2025-06-30
By invitation
MoonLake Immunotherapeutics AG
Phase 3
835
Catania, Chieti, Cona, Florence, Milan, Modena, Naples, Perugia
2025-06-27
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Bergamo, Bologna, Brescia, Meldola, Milan, Pavia, Perugia, Pesaro
2025-06-04
Recruiting
AstraZeneca
Phase 3
1,220
Bologna, Milan, Palermo, Perugia, Pisa, Roma, Rozzano
2025-05-06
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Ancona, Bologna, Civitanova Marche, Milan, Pagani, Palermo, Perugia, Pescara
2025-05-05
Active, closed
Novartis Pharmaceuticals
Phase 3
246
Ancona, Caserta, Grosseto, Milan, Rozzano, Perugia, Pordenone, Salerno
2025-04-30
Recruiting
Physica TT Tibial Plate Follow up Study
NCT06337123Knee Arthropathy
Limacorporate S.p.a
Observational
130
Forte dei Marmi, Messina, Perugia
2025-04-15
Recruiting
BeOne Medicines
Phase 3
250
Bari, Florence, Milan, Naples, Novara, Pavia, Perugia, Roma
2025-04-10
Not yet open
Certmedica International GmbH
Not applicable
240
Pisa, Chieti, Perugia
2025-04-01
Active, closed
Immutep S.A.S.
Phase 3
756
Avellino, Aviano, Candiolo, Milan, Naples, Perugia, Reggio Emilia, Terni
2025-03-21
Recruiting
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 3
339
Bologna, Genova, Palermo, Pescara, Perugia, Ravenna, Roma, Torino
2025-02-27
Recruiting
University Of Perugia
Not applicable
51
Perugia
2025-02-25
Recruiting
Bristol-Myers Squibb
Phase 3
530
Naples, Milan, Rome, Perugia, Peschiera del Garda, Bologna
2025-02-25
Recruiting
Interdisciplinary Counselling in DIAbetes
NCT07583355Type 2 Diabetes
Centro Universitario Ricerca Interdipartimentale Attivita' Motoria
Not applicable
123
Perugia
2025-02-12
Active, closed
AbbVie
Phase 3
468
Florence, Milan, Naples, Rome, Latina, Pavia, Perugia, Udine
2025-02-10
Recruiting
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
NCT06651970Chronic Lymphocytic Leukaemia, Moderate to Severe Cardiac Impairment
DrugAcalabrutinib
AstraZeneca
Phase 4
60
Cagliari, Florence, Milan, Pavia, Perugia
2025-02-04
Active, closed
EXErcise in MIGraine
NCT07508449Migraine in Adults
Centro Universitario Ricerca Interdipartimentale Attivita' Motoria
Not applicable
140
Perugia
2025-02-03
Recruiting
Azienda Ospedaliera di Perugia
Not applicable
35
Bari, Torino, Milan, Perugia
2025-02-01
Active, closed
AbbVie
Phase 1
4
Milan, Bologna, Perugia
2025-01-27
Not yet open
Centro Universitario Ricerca Interdipartimentale Attivita' Motoria
Observational
544
Perugia
2025-01-15
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
290
Alessandria, Padova, Perugia, Rome, Siena, Verona
2025-01-15
Recruiting
International Care Bundle Evaluation in Cerebral Hemorrhage Research
NCT06429332Intracerebral Hemorrhage, Intracerebral Haemorrhage, Intraventricular Hemorrhage, Stroke
Region Skane
Phase 4
3,500
Avezzano, Città di Castello, Gubbio, Perugia, Roma
2025-01-07
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Bari, Cona, Florence, Milan, Novara, Padova, Palermo, Perugia
2025-01-03
Recruiting
Cytokinetics
Phase 3
1,800
Brescia, Rimini, Arzignano, Bergamo, Milan, Sesto San Giovanni, Perugia, Cona
2024-12-19
Active, closed
Janssen Research & Development, LLC
Phase 3
655
Milan, Palermo, Perugia, Pisa, Roma, Rozzano, Udine
2024-12-04
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Ancona, Bergamo, Brescia, Genova, Milan, Pescara, Perugia, Pisa
2024-10-29
Recruiting
The Sagittarius Trial
NCT06490536Colon Cancer Stage II, Colon Cancer Stage III
DrugsFolinic acid·Panitumumab·Pertuzumab·Temozolomide
IFOM ETS - The AIRC Institute of Molecular Oncology
Phase 3
700
Biella, Brescia, Genova, Milan, Rozzano, Novara, Parma, Perugia
2024-10-22
Recruiting
Enhancing Palliative Care in ICU
NCT06605079Palliative Care
Charite University, Berlin, Germany
Not applicable
2,040
Perugia, Salerno, Terni
2024-10-10
Active, closed
Incyte Corporation
Phase 3
349
Catania, Chieti, L’Aquila, Milan, Naples, Perugia, Pisa, Rome
2024-10-10
Recruiting
Primary Cardiac Lymphoma: Italian Multicenter Experience
NCT05819528Primary Cardiac Lymphoma
Fondazione Italiana Linfomi - ETS
Observational
43
Bergamo, Brescia, Ferrara, Milan, Perugia, Pisa, Roma, Sassari
2024-10-02
Active, closed
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
NCT06431373Uveitis, Posterior, Uveitis, Intermediate, Uveitis
Priovant Therapeutics, Inc.
Phase 3
371
Perugia, Milan, Reggio Emilia, Roma
2024-09-11
Active, closed
AstraZeneca
Phase 2
194
Genoa, Meldola, Milan, Naples, Orbassano, Perugia, Rozzano, Udine
2024-08-27
Active, closed
Servier Bio-Innovation LLC
Phase 1/2
102
Aviano, Meldola, Milan, Naples, Perugia, Roma, Rozzano
2024-08-07
Active, closed
Novartis Pharmaceuticals
Phase 3
162
Milan, Perugia
2024-06-28
Recruiting
Immunocore Ltd
Phase 3
680
Bari, Bergamo, Meldola, Milan, Modena, Naples, Padova, Perugia
2024-06-05
Active, closed
Janssen Research & Development, LLC
Phase 2
333
Bari, Ferrara, Florence, Milan, Novara, Padova, Palermo, Perugia
2024-05-30
Active, closed
Eli Lilly and Company
Phase 3
10,000
Bologna, Ferrara, Genova, Milan, Palermo, Perugia, Pisa, Roma
2024-04-30
Recruiting
Centro di Riferimento Oncologico - Aviano
Phase 2
45
Aviano, Florence, Lido di Camaiore, Meldola, Monza, Padova, Parma, Perugia
2024-03-15
Active, closed
Sanofi
Phase 3
464
Turin, Chieti, Modena, Naples, Perugia
2024-02-29
Recruiting
AstraZeneca
Phase 3
5,250
Ancona, Florence, Genoa, Mestre, Milan, Naples, Pavia, Perugia
2024-02-21
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
DrugTarlatamab
Amgen
Phase 3
404
Aviano PN, Milan, Orbassano, Padova, Perugia, Pisa, Reggio Emilia, Rozzano MI
2024-02-20
Recruiting
Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer
NCT07288632Venous Thromboembolism (VTE), NSCLC (Advanced Non-small Cell Lung Cancer)
University Of Perugia
Observational
500
Perugia
2024-02-09
Active, closed
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
NCT05853575Advanced Cancer, Metastatic Cancer, Malignant Neoplasm of Lung
DrugAdagrasib
Mirati Therapeutics Inc.
Phase 2
200
Pesaro, Novara, Candiolo, Milan, Perugia, Roma
2024-02-01
Recruiting
Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication
NCT06049654Aortic Valve Stenosis, Structural Valve Deterioration
Fundación EPIC
Not applicable
104
Alessandria, Brescia, Perugia
2024-02-01
Recruiting
Insel Gruppe AG, University Hospital Bern
Observational
2,800
Naples, Palermo, Perugia, Reggio Emilia
2024-01-01
Recruiting
ETOP IBCSG Partners Foundation
Phase 2
44
Meldola, Milan, Perugia
2023-12-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
868
Bari, Aviano, Udine, Milan, Naples, Perugia, Catania, Cuneo
2023-12-06
Active, closed
Regeneron Pharmaceuticals
Phase 3
733
Meldola, Turin, Palermo, Milan, Modena, Naples, Perugia, Pisa
2023-11-14
Active, closed
BeOne Medicines
Phase 3
652
Bologna, Ferrara, Milan, Novara, Padova, Perugia
2023-11-11
Recruiting
Oxygen Extraction-guided Transfusion
NCT06102590Blood Transfusion
Università degli Studi di Ferrara
Not applicable
324
Ferrara, Perugia, Siena
2023-11-04
Recruiting
W.L.Gore & Associates
Not applicable
244
Milan, Perugia, Roma, Turin
2023-10-17
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
78
Florence, Meldola, Perugia, Ravenna, Rimini, Roma, Siena
2023-07-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Milan, Siena, Perugia, Naples
2023-07-19
Recruiting
Use of Shockwave M5+/L6 IVL Catheter (Intravascular Lithotripsy) in Hostile and Calcified Iliac Access
NCT05880641Aortic Diseases, Aorto-Iliac Atherosclerosis, Peripheral Arterial Disease
EndoCore Lab s.r.l.
Observational
40
Ancona, Bologna, Rome, Florence, Perugia, Padova
2023-06-26
Recruiting
Servier Affaires Médicales
Phase 3
245
Meldola, Brescia, Genova, Perugia
2023-06-14
Active, closed
ETOP IBCSG Partners Foundation
Phase 2
68
Perugia, Rome, Treviso
2023-06-12
Recruiting
Azienda Ospedaliero-Universitaria di Parma
Not applicable
300
Palermo, Perugia
2023-05-31
Active, closed
Toward Molecular Profiling of Parkinson's Disease in Easily Accessible Biological Matrices
NCT07480187Parkinson Disease, Synucleinopathy, Alzheimer Disease
Azienda Ospedaliera di Perugia
Not applicable
340
Messina, Milan, Perugia
2023-05-20
Active, closed
ETOP IBCSG Partners Foundation
Phase 2
60
Perugia
2023-03-27
Active, closed
Bristol-Myers Squibb
Phase 3
579
Genova, Siena, Bari, Milan, Naples, Perugia, Roma
2023-03-06
Active, closed
Kite, A Gilead Company
Phase 3
300
Bologna, Brescia, Milan, Perugia, Reggio Calabria, Rome, Rozzano
2023-02-10
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,564
Ancona, Naples, Meldola, Milan, Bari, Cuneo, Perugia, Rome
2023-01-16
Recruiting
Immunocore Ltd
Phase 3
540
Milan, Naples, Perugia, Roma, Siena
2022-12-19
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
180
Naples, Padova, Perugia, Roma, Rome, Siena
2022-11-30
Active, closed
Biogen
Phase 2
416
Tricase, Cefalù, Arzignano VI, Brescia, Milan, Perugia, Roma
2022-08-24
Active, closed
AstraZeneca
Phase 2
194
Candiolo, Milan, Naples, Padova, Perugia, Roma, Siena
2022-08-11
Active, closed
Incyte Corporation
Phase 1/2
53
Ravenna, Milan, Pavia, Monza, Candiolo, Pisa, Perugia
2022-07-19
Active, closed
Daiichi Sankyo
Phase 3
586
Bari, Chieti, Lucca, Milan, Orbassano, Parma, Perugia, Roma
2022-07-08
Recruiting
Pfizer
Phase 4
210
Bari, Perugia, Rome, Candiolo, Padova, Bologna, Milan, Naples
2022-07-05
Recruiting
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
NCT05430971Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Immune Oncology Research Institute
Observational
200
Perugia, Roma
2022-07-01
Recruiting
Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma
NCT06822855Classical Hodgkin Lymphoma, Classical Hodgkin Lymphoma Recurrent, Classical Hodgkin Lymphoma Refractory
Azienda USL Reggio Emilia - IRCCS
Observational
755
Milan, Reggio Emilia, Avellino, Brescia, Padova, Palermo, Perugia, Piacenza
2022-06-23
Recruiting
Telios Pharma, Inc.
Phase 1/2
70
Bologna, Milan, Perugia
2022-06-09
Recruiting
AbbVie
Phase 3
768
Misterbianco, Milan, Naples, Rome, Bari, Cremona, Messina, Perugia
2022-03-25
Active, closed
Daiichi Sankyo
Phase 3
740
Bari, Chieti, Lucca, Milan, Naples, Perugia, Rome, Varese
2022-03-04
Recruiting
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
NCT04988555Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute, Multiple Myeloma, Myelodysplastic Syndromes
DrugsAzoles·Gilteritinib·Azacitidine·Venetoclax
Sumitomo Pharma America, Inc.
Phase 1/2
606
Bologna, Busto Arsizio, Genoa, Meldola, Padua, Perugia, Ravenna, Rome
2022-02-28
Active, closed
MOVMEDIX
Not applicable
40
Perugia
2021-12-22
Recruiting
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
NCT04743765Hip Fractures, Myocardial Injury
Population Health Research Institute
Not applicable
1,100
Perugia, Genova, Milan
2021-11-22
Active, closed
Loxo Oncology, Inc.
Phase 3
282
Rionero in Vulture, Bergamo, Brescia, Meldola, Milan, Monza, Novara, Perugia
2021-09-23
Active, closed
Bristol-Myers Squibb
Phase 3
338
Catania, Pavia, Perugia, Roma
2021-09-15
Recruiting
L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.
Not applicable
78
Arezzo, Florence, Genova, Milan, Palermo, Perugia, Pistoia
2021-09-14
Active, closed
HUYABIO International, LLC.
Phase 3
450
Milan, Perugia, Bari, Bologna, Misterbianco, Naples, Palermo, Roma
2021-08-12
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 3
800
Ancona, Cremona, Empoli, Florence, Milan, Perugia, Treviso
2021-08-04
Active, closed
Hoffmann-La Roche
Phase 3
451
Chieti, Bari, Trieste, Rome, Milan, Torrette - Ancona, Florence, Perugia
2021-07-14
Active, closed
Daiichi Sankyo
Phase 2
155
Bergamo, Bologna, Monza, Naples, Perugia
2021-06-03
Recruiting
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
NCT04503395Aortic Aneurysm, Abdominal
FCRE (Foundation for Cardiovascular Research and Education)
Not applicable
204
Bologna, Genova, Milan, Perugia, Turin, Verona
2021-05-21
Active, closed
EMN Trial Office S.r.l. Impresa Sociale
Phase 2
50
Bari, Milan, Perugia, Roma, Trieste, Udine
2021-03-21
Active, closed
Karyopharm Therapeutics Inc
Phase 2
112
Meldola, Florence, Latina, Perugia, Varese
2021-03-17
Active, closed
German CLL Study Group
Phase 3
897
Catania, Ferrara, Mestre, Milan, Perugia, Roma, Torino
2021-03-01
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Not applicable
38
Bari, Florence, Genova, Perugia, Roma, Rozzano
2021-02-12
Active, closed
Galderma R&D
Phase 3
500
Catania, Chieti, Genova, L’Aquila, Modena, Naples, Parma, Perugia
2021-01-11
Active, closed
GlaxoSmithKline
Phase 2/3
758
Ancona, Avellino, Florence, Milan, Monza, Naples, Orbassano to, Perugia
2020-12-08
Active, closed
GlaxoSmithKline
Phase 3
325
Bologna, Brescia, Catanzaro, Milan, Pavia, Perugia, Ravenna, Roma
2020-04-02
Active, closed
BeOne Medicines
Phase 1
437
Milan, Perugia, Ravenna, Roma, Verona
2020-03-24
Recruiting
Peripheral Extreme Revascularization in "No-option" Patiens With Chronic Limb Threatening Ischemia
NCT06277362Peripheral Arterial Disease, Critical Limb-Threatening Ischemia, Diabetic Foot
EndoCore Lab s.r.l.
Observational
50
Ancona, Belluno, Cesena, Conegliano, Naples, Reggio Emilia, Trento, Perugia
2020-01-31
Active, closed
Regeneron Pharmaceuticals
Phase 2
515
Milan, Bologna, Livorno, Novara, Perugia, Ravenna, Reggio Emilia, Varese
2019-11-13
Active, closed
Bristol-Myers Squibb
Phase 3
790
Palermo, Bergamo, Milan, Naples, Padova, Perugia, Siena
2019-10-28
Recruiting
ALFAOMEGA Master Observational Trial
NCT04120935Colorectal Cancer
IFOM ETS - The AIRC Institute of Molecular Oncology
Observational
3,000
Biella, Milan, Padova, Perugia, Pisa, Ravenna, Candiolo, Orbassano
2019-10-15
Active, closed
Development of a Web-based Multicenter Registry on the Use of oXiris Membrane for EBPTs in Critically Ill Patients
NCT03807414Critical Illness, Acute Kidney Injury, Sepsis, Systemic Inflammatory Response Syndrome
Careggi Hospital
Observational
270
Esine, Empoli, San Donato Milanese, Benevento, Florence, Naples, Pavia, Perugia
2019-06-28
Active, closed
Exelixis
Phase 3
855
Meldola, Faenza, Arezzo, Modena, Padova, Pavia, Perugia, Terni
2019-06-25
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
2,000
Acquaviva delle Fonti, Arezzo, Brescia, Florence, Milan, Negrar, Pavia, Perugia
2019-06-24
Active, closed
Eisai Inc.
Phase 3
1,906
Tricase, Cefalù, Genova, Milan, Monza, Naples, Perugia, Pisa
2019-03-27
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Faenza, Milan, Naples, Padova, Parma, Perugia, Pisa, Roma
2019-01-25
Active, closed
AstraZeneca
Phase 2
367
Avellino, Florence, Milan, Orbassano, Padova, Parma, Perugia, Peschiera del Garda
2019-01-09
Recruiting
Hoffmann-La Roche
Phase 3
1,000
Chieti, Bari, Trieste, Rome, Milan, Torrette - Ancona, Florence, Perugia
2018-09-20
Active, closed
Hoffmann-La Roche
Phase 3
257
Naples, Rome, Milan, Orbassano, Perugia
2018-08-16
Active, closed
Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
NCT03386513Blastic Plasmacytoid Dendritic Cell Neoplasm, Myeloproliferative Neoplasm
DrugIMGN632
AbbVie
Phase 1/2
179
Bologna, Meldola, Milan, Perugia
2018-01-02
Active, closed
AstraZeneca
Phase 3
1,324
Benevento, Meldola, Milan, Naples, Perugia, Pisa, Roma, Rozzano
2017-10-11
Active, closed
Novartis Pharmaceuticals
Phase 2
29
Milan, Perugia
2017-07-04
Active, closed
Pfizer
Phase 3
296
Catania, Monza, Milan, Rozzano, Perugia, Pordenone, Parma, Roma
2017-04-27
Active, closed
Xcovery Holdings, Inc.
Phase 3
290
Milan, Perugia, Sondrio
2016-06
Active, closed
Hoffmann-La Roche
Phase 2
534
Naples, Rome, Milan, Pisa, Perugia, Padova
2015-11-19
Active, closed
AstraZeneca
Phase 3
510
Bari, Genova, Livorno, Milan, Naples, Orbassano, Parma, Perugia
2013-09-25
Rows per page Showing 1–141 of 141
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/perugia

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 141 of those studies with a site in Perugia.

How many clinical trials are recruiting in Perugia?

71 of the 141 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 4 have not yet opened recruitment, 65 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Perugia), 141 studies
PhaseStudiesRecruitingShare
Phase 3662846.8%
Phase 225717.7%
Not applicable191413.5%
Observational171412.1%
Phase 1/2523.5%
Phase 4442.8%
Phase 2/3322.1%
Phase 1201.4%

Most active sponsors

Lead sponsors with the most studies (Perugia)
Lead sponsorStudiesRecruiting
AstraZeneca105
ETOP IBCSG Partners Foundation75
Hoffmann-La Roche73
Bristol-Myers Squibb63
Janssen Research & Development, LLC63
AbbVie52
Novartis Pharmaceuticals51
Merck Sharp & Dohme LLC42
BeOne Medicines31
Centro Universitario Ricerca Interdipartimentale Attivita' Motoria31
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.